Similar articles

• [Enteral hyperoxalosis due to therapy with a somatostatin analog].

  Ranft K, Eibl-Eibesfeldt B. Ranft K, et al. Dtsch Med Wochenschr. 1990 Feb 2;115(5):179-81. doi: 10.1055/s-2008-1064989. Dtsch Med Wochenschr. 1990. PMID: 2298134 German.
• Carcinoid crisis induced by repeated abdominal examination.

  Morrisroe K, Sim IW, McLachlan K, Inder WJ. Morrisroe K, et al. Intern Med J. 2012 Mar;42(3):342-4. doi: 10.1111/j.1445-5994.2012.02719.x. Intern Med J. 2012. PMID: 22432991 No abstract available.
• [A favorable response to the somatostatin analog SMS 201-995 in a patient with the carcinoid syndrome].

  Del Val A, Ponce J, Talens A, Martí-Bonmati L, Garrigues V, Berenguer J. Del Val A, et al. Rev Esp Enferm Dig. 1991 Mar;79(3):215-7. Rev Esp Enferm Dig. 1991. PMID: 2043408 Spanish.
• [Treatment of carcinoid tumor with a long-acting somatostatin analog].

  Werling K, Lengyel G, Fehér E, Jakab Z, Besznyák I, Feher J. Werling K, et al. Orv Hetil. 1993 Feb 7;134(6):301-5. Orv Hetil. 1993. PMID: 8430017 Review. Hungarian.
• [Current treatment of carcinoid tumor].

  Elizalde I, Borda F. Elizalde I, et al. Gastroenterol Hepatol. 2002 Oct;25(8):508-13. doi: 10.1016/s0210-5705(02)70302-6. Gastroenterol Hepatol. 2002. PMID: 12361534 Review. Spanish. No abstract available.